Article info
Neurological picture
Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS
- Correspondence to Dr Teppei Komatsu, Department of Neurology, Jikei University School of Medicine, Minato-ku, Tokyo 105-8461, Japan; teppeinoieni.coicoi{at}jikei.ac.jp
Citation
Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS
Publication history
- Received July 17, 2018
- Revised September 3, 2018
- Accepted September 5, 2018
- First published October 8, 2018.
Online issue publication
December 14, 2018
Article Versions
- Previous version (14 December 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.